Literature DB >> 12712375

How oncologists discuss complementary therapy use with their patients: an audio-tape audit.

Penelope E Schofield1, Ilona Juraskova, Phyllis N Butow.   

Abstract

Understanding the dynamics of oncologist-patient communication regarding complementary therapy (CT) use is essential for the development of much-needed clinical guidelines. Discussions of CT use in 314 audio-taped initial consultations between cancer patients and their oncologists were identified and coded. Patients' anxiety levels and coping styles were also assessed. Reference to CT use was found in 91 consultations (29%). Patients and kin initiated most CT discussions, commonly during discussions of patients' medical history, treatment options or prognosis. In half of these discussions, patients volunteered that they were currently using a CT or were considering its use. Discussion of CT use was more likely to occur in consultations with patients who were younger, were better educated, spoke poorer English, had metastatic disease or limited life expectancy and expressed higher levels of fighting spirit and anxious preoccupation and lower levels of fatalism. The most commonly discussed CTs were: changes in diet; use of multivitamins, vitamin C or antioxidants; and having a positive attitude or fighting spirit. The doctor's overall response to CTs was most frequently coded as "encouraging", although 35% of attempts to initiate discussion were ignored by the oncologist. Doctors were more likely to make encouraging statements about CTs typically perceived to be potentially helpful versus potentially harmful. The current findings point to a need for practical consensus on how to communicate with cancer patients on the subject of CT use so that patients can receive the support and guidance that they are seeking from their oncologists.

Entities:  

Mesh:

Year:  2003        PMID: 12712375     DOI: 10.1007/s00520-002-0420-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  The physician and unorthodox cancer therapies. The American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

2.  Development of a questionnaire measure of adjustment to cancer: the MAC scale.

Authors:  M Watson; S Greer; J Young; Q Inayat; C Burgess; B Robertson
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

3.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

4.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

5.  The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study.

Authors:  T Risberg; E Lund; E Wist; O Dahl; S Sundstrøm; O K Andersen; S Kaasa
Journal:  Eur J Cancer       Date:  1995-10       Impact factor: 9.162

6.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Patterns of alternative medicine use by cancer patients.

Authors:  S D Begbie; Z L Kerestes; D R Bell
Journal:  Med J Aust       Date:  1996-11-18       Impact factor: 7.738

8.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

9.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.

Authors:  Katsuya Tasaki; Gertraud Maskarinec; Dianne M Shumay; Yvonne Tatsumura; Hisako Kakai
Journal:  Psychooncology       Date:  2002 May-Jun       Impact factor: 3.894

10.  Promoting patient participation and shortening cancer consultations: a randomised trial.

Authors:  R F Brown; P N Butow; S M Dunn; M H Tattersall
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more
  15 in total

1.  Practitioners' sources of clinical information on complementary and alternative medicine in oncology.

Authors:  Michael Joseph Dooley; Diana Yu-Lin Lee; Jennifer Lillian Marriott
Journal:  Support Care Cancer       Date:  2003-12-04       Impact factor: 3.603

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.

Authors:  Jon Tilburt; Kathleen J Yost; Heinz-Josef Lenz; María Luisa Zúñiga; Thomas O'Byrne; Megan E Branda; Aaron L Leppin; Brittany Kimball; Cara Fernandez; Aminah Jatoi; Amelia Barwise; Ashok Kumbamu; Victor Montori; Barbara A Koenig; Gail Geller; Susan Larson; Debra L Roter
Journal:  Oncologist       Date:  2019-05-17

4.  An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits.

Authors:  Christopher J Koenig; Evelyn Y Ho; Laura Trupin; Daniel Dohan
Journal:  Patient Educ Couns       Date:  2015-03-14

5.  Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer.

Authors:  Penelope E Schofield; M R Stockler; D Zannino; N C Tebbutt; T J Price; R J Simes; N Wong; N Pavlakis; D Ransom; E Moylan; C Underhill; D Wyld; I Burns; R Ward; N Wilcken; M Jefford
Journal:  Support Care Cancer       Date:  2015-06-21       Impact factor: 3.603

6.  Negotiating complementary and alternative medicine use in primary care visits with older patients.

Authors:  Christopher J Koenig; Evelyn Y Ho; Vivien Yadegar; Derjung M Tarn
Journal:  Patient Educ Couns       Date:  2012-04-06

7.  Potential of chemotherapy-herb interactions in adult cancer patients.

Authors:  Jeannine S McCune; Amy J Hatfield; Anne A R Blackburn; Patricia O Leith; Robert B Livingston; Georgiana K Ellis
Journal:  Support Care Cancer       Date:  2004-02-27       Impact factor: 3.603

8.  Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visits.

Authors:  Debra L Roter; Kathleen J Yost; Thomas O'Byrne; Megan Branda; Aaron Leppin; Brittany Kimball; Cara Fernandez; Aminah Jatoi; Ashok Kumbamu; Victor Montori; Barbara Koenig; Gail Geller; Susan Larson; Jon Tilburt
Journal:  Patient Educ Couns       Date:  2016-06-04

9.  Physician-patient communication about dietary supplements.

Authors:  Derjung M Tarn; Debora A Paterniti; Jeffrey S Good; Ian D Coulter; James M Galliher; Richard L Kravitz; Arun S Karlamangla; Neil S Wenger
Journal:  Patient Educ Couns       Date:  2013-03-07

10.  Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncology.

Authors:  Claudia Bozza; Lorenzo Gerratana; Debora Basile; Maria Grazia Vitale; Michele Bartoletti; Elisa Agostinetto; Stefania Russo; Alessandro Follador; Elisa De Carlo; Nicoletta Pella; Roberta Sottile; Gianpiero Fasola; Fabio Puglisi
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.